Dr. Carissa Chu
Urologist
1 Podcast on BackTable
Dr. Carissa Chu is a urologist and Assistant Professor of Urology at UCSF in San Francisco, California.
Learn from the experiences and expertise of Dr. Carissa Chu and other leading voices in your specialty on the BackTable app.
Episode # 280 • 16 Dec 2025
Genomic Classifiers in Bladder Cancer Management
Can genomic classifiers close the gap between what we see and what a tumor will do? In this episode of BackTable Urology, Dr. Carissa Chu (UCSF) joins Dr. Ruchika Talwar (Vanderbilt) to explore how genomic classifiers are reshaping the way clinicians diagnose and manage bladder cancer.
This podcast is supported by:
More from Dr. Carissa Chu
About
Dr. Carissa Chu is a surgeon specializing in urologic cancers with experience in open and minimally invasive techniques. Chu's research focuses on bladder and prostate cancer, including mechanisms of drug resistance and biological variation across different stages of disease. She runs a translational research lab that studies tumor tissues with the aim of improving treatments and identifying biomarkers to personalize care.
Chu earned her medical degree at UCSF, where she also completed a residency in urologic surgery. She completed a fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center. Chu has earned multiple awards for her excellence in leadership, research and clinical care. These include the Peter T. Scardino Award for Leadership, a Young Investigator Award from the American Society of Clinical Oncology and a Ferdinand C. Valentine Fellowship for Research in the Field of Urology from the New York Academy of Medicine. She is also the recipient of training grants from the National Institutes of Health.
Visit UCSF to learn more about Dr. Carissa Chu.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.